HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 291/5/R1275    most recent 00187.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by da Silva, A. A. Articles by Hall, J. E. Search for Related Content PubMed PubMed Citation Articles by da Silva, A. A. Articles by Hall, J. E.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity

Department of Physiology and Biophysics, Center of Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Mississippi

Submitted 15 May 2006 ; accepted in final form 13 June 2006

This study examined the importance of direct central nervous system (CNS) actions and increased adrenergic activity in mediating the chronic antidiabetic and cardiovascular actions of leptin. Insulin-deficient rats (streptozotocin, 50 mg/kg) were used to examine the effects of leptin on glucose homeostasis independent of changes in insulin. Male Sprague-Dawley rats were instrumented with arterial and venous catheters and intracerebroventricular cannula for 24-h/day blood pressure (BP) and heart rate (HR) monitoring and intravenous and intracerebroventricular infusions. Insulin-deficient diabetes was associated with marked hyperglycemia, hyperphagia, decreased BP, and pronounced fall in HR. Leptin treatment, intravenous or intracerebroventricular, completely restored to control values plasma glucose levels (384 ± 58 to 102 ± 28 and 307 ± 38 to 65 ± 7 mg/dl, respectively), food intake, BP, and HR (304 ± 8 to 364 ± 7 and 317 ± 13 to 423 ± 9 bpm, respectively). Combined blockade of ₁-, ₁-, and ₂-adrenergic receptors attenuated the rise in HR by 30 to 50% but had no effect on the antidiabetic and dietary actions of leptin. Blockade of ₃-adrenergic receptors did not attenuate the chronic cardiovascular or metabolic effects of leptin. These data demonstrate that leptin, via its direct actions in the CNS, has powerful antidiabetic actions in insulin-deficient rats independent of increased peripheral ₁, ₁, ₂, and ₃-adrenergic activity. Leptin also exerts important long-term cardiovascular actions that are partially mediated via ₁- and ₁/₂-adrenergic activation. These findings provide new insights into novel pathways for long-term control of glucose homeostasis and cardiovascular regulation.

glucose; insulin; blood pressure; food intake; diabetes; sympathetic activity; central nervous system; heart rate; kidney; appetite

This article has been cited by other articles:

				A. A. da Silva, J. M. do Carmo, J. N. Freeman, L. S. Tallam, and J. E. Hall A Functional Melanocortin System May Be Required for Chronic CNS-Mediated Antidiabetic and Cardiovascular Actions of Leptin Diabetes, August 1, 2009; 58(8): 1749 - 1756. [Abstract] [Full Text] [PDF]